uniQure NV (QURE) Company Sales Volume

Symbol and logo of brand uniQure (QURE)

Sales revenue for uniQure N.V. (QURE) on the GURU.Markets base chart, which currently stands at 0.02, is supported by strong R&D potential and a team of geneticists. Growth is based on management's experience in bringing hemophilia treatments to market and expansion into neurobiology. Operational stability is guaranteed by established redundant logistics chains between US and European production sites.

uniQure Pharma (QURE) Company Sales: for the period 07/04/2022 - 11/18/2026

Analytical breakdowns for uniQure N.V.

- share price and expert price forecast:
General company analysis:QURE, uniqure.com
Manufactured product of uniQure

Sales for uniQure N.V. (QURE) reflect the scale of gene technology commercialization through the total volume of products sold. This indicator captures the direct return from operating activities, measuring the cash inflow from market sales. By analyzing the company's commercial realization volumes, investors assess margin stability and expansion rates. Growth in this metric confirms the effectiveness of overcoming stringent FDA regulatory controls. Patent protection for AAV vectors guarantees the sustainability of these revenues.

Analysis of competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales